ArticleScientific reports2026

Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis.

Onuma Sattayalertyanyong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.